These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6224367

  • 21. Ion binding by small molecular weight substances (1,000-10,000 daltons) in urine.
    Nicar MJ, Holt K, Pak CY.
    Invest Urol; 1980 Sep; 18(2):162-4. PubMed ID: 7410030
    [Abstract] [Full Text] [Related]

  • 22. Body size and 24-hour urine composition.
    Taylor EN, Curhan GC.
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [Abstract] [Full Text] [Related]

  • 23. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y.
    Nephrologie; 1999 Dec; 20(7):363-9. PubMed ID: 10642984
    [Abstract] [Full Text] [Related]

  • 24. [Effect of high-dose vitamin C on the formation of experimental renal stones in the rat].
    Cai SL, Wei KX, Yang SS.
    Zhonghua Wai Ke Za Zhi; 1985 Mar; 23(3):174-7, 192. PubMed ID: 3158497
    [No Abstract] [Full Text] [Related]

  • 25. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F, Lacour B, Daudon M.
    Nephrologie; 1996 Mar; 17(3):157-62. PubMed ID: 9064564
    [Abstract] [Full Text] [Related]

  • 26. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ, Coe FL.
    Scand J Urol Nephrol Suppl; 1980 Mar; 53():265-71. PubMed ID: 6938003
    [Abstract] [Full Text] [Related]

  • 27. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
    Massey LK, Kynast-Gales SA.
    J Am Diet Assoc; 2001 Mar; 101(3):326-31. PubMed ID: 11269613
    [Abstract] [Full Text] [Related]

  • 28. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Mar; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 29. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A, Pizá P, García-Raja A.
    Arch Esp Urol; 1999 Mar; 52(1):94-9. PubMed ID: 10101897
    [Abstract] [Full Text] [Related]

  • 30. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S, Kalaiselvi P, Varalakshmi P.
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [Abstract] [Full Text] [Related]

  • 31. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K, Mayne K, Doyle IR, Ryall RL.
    Scanning Microsc; 1994 Feb; 8(3):523-30. PubMed ID: 7747154
    [Abstract] [Full Text] [Related]

  • 32. [Nephrolithiasis--correlation of calculus type and pathogen spectrum. Calculus analysis and microbiologic diagnosis in 173 surgically treated patients].
    Friesen A, Stern J, Hofstetter AG, Schilling A.
    Fortschr Med; 1984 Nov 22; 102(43):1109-12. PubMed ID: 6392048
    [Abstract] [Full Text] [Related]

  • 33. A method for discrimination between calcium oxalate kidney stone formers and normals.
    Sarig S, Garti N, Azoury R, Wax Y, Perlberg S.
    J Urol; 1982 Sep 22; 128(3):645-9. PubMed ID: 6214645
    [Abstract] [Full Text] [Related]

  • 34. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL, Parks JH.
    Urol Clin North Am; 1981 Jun 22; 8(2):227-44. PubMed ID: 7268958
    [No Abstract] [Full Text] [Related]

  • 35. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M, Tsujikawa K, Tei N, Yoshimura K, Okuyama A.
    Int J Urol; 2006 Mar 22; 13(3):197-201. PubMed ID: 16643608
    [Abstract] [Full Text] [Related]

  • 36. [Inhibitors of crystallization and calcium nephrolithiasis].
    Baumann JM.
    Ther Umsch; 1980 May 22; 37(5):363-72. PubMed ID: 6248999
    [No Abstract] [Full Text] [Related]

  • 37. [Uric acid and oxalate lithiasis. Physico-chemical and crystallo-chemical explanation of the relationship].
    Leskovar P.
    Z Urol Nephrol; 1980 Mar 22; 73(3):211-21. PubMed ID: 7434985
    [Abstract] [Full Text] [Related]

  • 38. [Remarks on the metabolic evaluation of renal lithiasis].
    Thomas J.
    J Urol (Paris); 1984 Mar 22; 90(1):1-5. PubMed ID: 6725970
    [Abstract] [Full Text] [Related]

  • 39. [Physiopathological diagnosis of changes in uric acid metabolism: hyperuricuria and nephrolithiasis].
    García Puig J, Mateos Antón F, Ramos T.
    Med Clin (Barc); 1987 Sep 19; 89(8):339-47. PubMed ID: 3320609
    [No Abstract] [Full Text] [Related]

  • 40. [The proteolysis-ion theory of the pathogenesis of nephrolithiasis].
    Edinyĭ IuG, Dziurak VS, Zheltovskaia NI.
    Urol Nefrol (Mosk); 1989 Sep 19; (6):37-40. PubMed ID: 2694566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.